|
RBBP8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
2.398600E-04 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
2.69717581602436E-12 |
| Stage1-vs-Stage2 |
1.074110E-02 |
| Stage1-vs-Stage3 |
4.459400E-01 |
| Stage1-vs-Stage4 |
7.630000E-01 |
| Stage2-vs-Stage3 |
7.032300E-02 |
| Stage2-vs-Stage4 |
2.999900E-02 |
| Stage3-vs-Stage4 |
4.071200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.361900E-04 |
| Normal-vs-Asian |
2.11586304033062E-12 |
| Caucasian-vs-AfricanAmerican |
2.676800E-01 |
| Caucasian-vs-Asian |
1.682840E-01 |
| AfricanAmerican-vs-Asian |
6.549600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66433533621557E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.234100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
6.09039485510721E-11 |
| Normal-vs-Age(81-100Yrs) |
1.175950E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.600600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.198100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.992800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.614190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.108200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.750400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.087800E-02 |
| Classical-VS-Follicular |
3.68919999993444E-07 |
| Classical-VS-Other |
1.044390E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
2.09149999998992E-05 |
| Tall-VS-Other |
1.130050E-02 |
| Tall-VS-Normal |
2.12940776123105E-12 |
| Follicular-VS-Other |
9.384800E-01 |
| Follicular-VS-Normal |
2.51559999997486E-06 |
| Other-VS-Normal |
1.090380E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
7.05610014861691E-11 |
| N0-vs-N1 |
9.045900E-02 |
|
|
